Deep Proteomic Investigation of Metabolic Adaptation in Mycobacteria under Different Growth Conditions

• Published in: Proteomes Vol. 11; no. 4; p. 39
• Main Authors: Zmyslia, Mariia, Fröhlich, Klemens, Dao, Trinh, Schmidt, Alexander, Jessen-Trefzer, Claudia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.12.2023
• Subjects: Adaptation (Physiology); Carbon; carbon source; Carbon sources; Causes of; Cell culture; Cholesterol; Development and progression; Disease; Drug development; Drug screening; Energy resources; Glucose; Glycerol; Growth conditions; Infections; Kinases; Labeling; Macrophages; Metabolism; Methods; Microbial metabolism; Microbiological research; Mortality; Mycobacteria; Mycobacterium; Physiological aspects; Physiology; Proteins; Proteomes; Proteomics; Tuberculosis; Germany; metabolism; carbon source; proteomics; mycobacteria
• ISSN: 2227-7382; 2227-7382
• DOI: 10.3390/proteomes11040039

Understanding the complex mechanisms of mycobacterial pathophysiology and adaptive responses presents challenges that can hinder drug development. However, employing physiologically relevant conditions, such as those found in human macrophages or simulating physiological growth conditions, holds promise for more effective drug screening. A valuable tool in this pursuit is proteomics, which allows for a comprehensive analysis of adaptive responses. In our study, we focused on , a model organism closely related to the pathogenic , to investigate the impact of various carbon sources on mycobacterial growth. To facilitate this research, we developed a cost-effective, straightforward, and high-quality pipeline for proteome analysis and compared six different carbon source conditions. Additionally, we have created an online tool to present and analyze our data, making it easily accessible to the community. This user-friendly platform allows researchers and interested parties to explore and interpret the results effectively. Our findings shed light on mycobacterial adaptive physiology and present potential targets for drug development, contributing to the fight against tuberculosis.